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PERBANDINGAN ANTARA KEBERKESANAN ELISA-CSA DAN ELISA-
rLECTIN YANG DISESUAIKAN DALAM PENGESANAN ANTIBODI ANTI-
AMEBA DALAM SAMPEL SERUM ORANG ASLI YANG TERPILIH 
 
 
ABSTRAK 
Orang Asli Malaysia tinggal di hutan pedalaman yang endemik terhadap amebiasis. 
Pemahaman terhadap prevalens dan taburan penyakit ini adalah penting untuk 
rancangan kawalan dan pencegahan. Salah satu penunjuk utama untuk penyakit ini 
adalah kehadiran antibodi anti-ameba yang sangat tinggi. Walau bagaimanapun, 
penyaringan berterusan antibodi menggunakan kit komersil adalah tidak praktikal 
kerana penglibatan kos yang tinggi. Kit buatan sendiri yang lebih murah dan memberi 
keputusan yang sahih harus diguna sebagai pengganti untuk menjimat kos dan 
kelestarian. Oleh yang demikian, kajian ini bertujuan untuk membandingkan 
keberkesanan ELISA-CSA (antigen larut kasar) dengan ELISA-rLectin (lektin 
rekombinan) dalam pengesanan antibodi anti-ameba yang terkandung dalam sampel 
serum Orang Asli yang telah  terlebih dahulu diuji dengan kit hemaglutinasi secara tidak 
langsung (IHA) komersial. CSA adalah dihasilkan daripada trofozoit Entamoeba 
histolytica yang dikultur secara axenik, sementara rLectin diekspress dan ditulenkan 
daripada Escherichia coli yang mengandung gen rekombinan itu. Pembangunan kedua-
dua ELISA itu melibatkan pengoptimuman kepekatan antigen, kadar pencairan serum 
dan antibodi yang dikonjugasi. Keberkesanan diagnostik kedua-dua ELISA itu 
dibanding dengan menggunakan 30 sampel serum positif dan negatif yang telah 
ditentukan oleh asai IHA komersial. Berdasarkan analisis lengkung ciri operasi 
penerima (ROC curve), kedua-dua ELISA itu menunjukkan prestasi diagnostik yang 
 x 
 
sangat baik. Apabila dibanding dengan ujian rujukan, persetujuan peratusan positif 
ELISA-CSA (91%) didapati lebih tinggi daripada ELISA- rLectin (61%), manakala 
kedua-dua ELISA itu menunjukkan persetujuan peratusan negatif yang sama iaitu 97%. 
Menurut analisis densiti optik ELISA, nilai delta positif ELISA- CSA (0.4472) adalah 
lebih tinggi daripada nilai delta positif –ELISA-rLektin (0.2673), manakala nilai delta 
negatif ELISA-rLektin (-1.209) lebih rendah daripada nilai delta negatif ELISA-CSA (-
1.175). Kesimpulannya kajian ini menunjukka bahawa ELISA-CSA adalah lebih  
sensitif dalam mengesan kehadiran antibodi anti-ameba, sementara ELISA- rLectin 
lebih spesifik dalam menentukan kes-kes negatif. 
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COMPARISON OF THE EFFICIENCIES OF CUSTOMIZED CSA- AND 
rLECTIN-ELISAS FOR DETECTION OF ANTI-AMOEBIC ANTIBODY 
BASED ON SELECTED ABORIGINES SERUM SAMPLES 
 
 
ABSTRACT 
Orang Asli, the Malaysian aborigines live in remote jungles, are endemic for amoebiasis. 
Understanding the disease prevalence and distribution is important for the control and 
preventive measures. A major indicator that reflects on the disease incidence is the 
presence of highly elevated anti-amoebic antibody. However, continuous screening of 
the antibody using commercial kits is impractical due to the high cost. Cheaper but valid 
in-house customized assay should be employed instead to attain cost-effective and 
sustainable outcome. Hence, the presence study aimed to compare the efficiencies of 
customized crude soluble antigen (CSA)-ELISA and recombinant lectin (rLectin)- 
ELISA for detection of anti-amoebic antibody in selected Orang Asli serum samples, 
which were prior defined by commercial indirect haemagglutination assay (IHA). CSA 
was produced from axenically grown Entamoeba histolytica trophozoites, while rLectin 
was overexpressed and purified from Escherichia coli harbouring the corresponding 
recombinant gene. For the development of the two customized ELISAs, antigen 
concentration, serum and conjugated antibody dilutions were optimized. The 
efficiencies of both customised ELISAs were determined by 30 positive and negative 
serum samples pre-determined by commercial IHA. According to receiver operating 
characteristics (ROC) curve analysis, both customized ELISAs showed excellent 
diagnostic performances. As compared to the reference assay, the positive percentage 
agreement of CSA-ELISA (91%) was higher than that of rLectin-ELISA (61%), while 
 xii 
 
both ELISAs showed the same negative percentage agreement, which was 97%. 
According to analysis of ELISA ODs, the positive delta value for CSA-ELISA (0.4472) 
was higher than that of rLectin-ELISA (0.2673), while the negative delta value of 
rLectin-ELISA (-1.209) was lower than that of CSA-ELISA (-1.175). In conclusion, this 
study demonstrated that CSA-ELISA was more sensitive in detecting the presence of 
anti-amoebic antibody, while rLectin-ELISA was more specific in ruling out negative 
cases.  
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Entamoeba histolytica 
Amebiasis is an infection caused by E. histolytica, the protozoan parasite, which is 
the third leading cause of death worldwide after malaria and schistosomiasis (Huston 
& Sateriale 2011; Shahrul Anuar et al., 2012). There are six species in the genus of 
Entamoeba which are found in the intestinal lumen of humans, namely E. histolytica, 
Entamoeba dispar, Entamoeba moshkovskii, Entamoeba coli, Entamoeba polecki and 
Entamoeba hartmanni. Among them, E. histolytica is the only species that causes 
invasive disease resulting in diarrhoea, dysentery and liver abscess in human. Based 
on microscopic observations, all nuclei of E. histolytica, E. dispar and E. 
moshkovskii have a central karyosome, which differentiated them from the other non-
pathogenic Entamoeba species. Differentiation between the pathogenic E. histolytica 
from the two other non-pathogenic but morphologically similar Entamoeba is 
important for treatment purposes. The recent development of molecular diagnostics 
enables the differentiation among the three Entamoebas. E. moshkovskii is primarily 
considered to be a free-living ubiquitous amoeba found in anoxic sediments. 
Recently, a new species of E. bangladeshi was discovered but its importance to 
human health is basically unknown. It was found to be genetically more closely 
related to E. moshkovskii than E. histolytica (Lau et al., 2013).  
 
1.1.1 Life cycle of E. histolytica 
E. histolytica is a pathogenic protozoon which is transmitted through oral faecal 
route and human can acquire infection by accidental ingestion of the infective cyst of 
E. histolytica in the faecal contaminated food or water. The other amoeba species are 
important because they may be confused with E. histolytica in diagnostic 
investigations. The infection occurs usually in the large intestine and causes 
inflammation or abscess in other organs such as liver. The most common form of 
organ abscess caused by E. histolytica is amoebic liver abscess (ALA). The 
protozoan parasite life cycle consists of two forms, namely an infective cyst form 
and a motile pathogenic trophozoite form. 
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The cycle begins when human accidentally ingests food or drink contaminated with 
E. histolytica cyst (Figure 1.1). Each cyst transforms into four trophozoites through a 
process called excystation in the small intestine. The trophozoites multiply by binary 
fission and then transform into cysts. Both trophozoites and cysts are passed in the 
faeces. Cysts are typically found in formed stool, whereas trophozoites are typically 
found in diarrheal stool. The cysts can survive for days to weeks in the external 
environment and are responsible for transmission. The cysts are conferred protection 
by the presence of cyst walls. However, trophozoites that are passed in the stool are 
rapidly destroyed once outside the body as they do not have cyst walls. If the 
trophozoites were ingested, they would not survive in the human gastric environment. 
In many cases, the trophozoites remain confined to the intestinal lumen. Some 
patients may not show any symptom and they became asymptomatic carriers who 
pass cysts in their stool. In some patients the trophozoites invade the intestinal 
mucosa (intestinal disease), enter the bloodstream and spread to other organs such as 
the liver, brain, and lungs which result in extraintestinal diseases such as ALA. 
 
 
Figure 1.1: Life cycle of E. histolytica (CDC 2015) 
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1.1.2 Morphology 
E. histolytica trophozoite has a diameter of 12-60 µm and is surrounded by a three-
tiered, lipid-protein cell membrane and creates characteristic ameboid pseudopodia 
that allow it to move and participate in phagocytosis, a process of absorption of food 
particles. The cytoplasm is differentiated into ectoplasm and fine-grained endoplasm, 
which consists of cytosol and numerous cell organelles such as endosomes, 
lysosomes, Golgi apparatus, vacuoles with red blood cells and glycogen mass. E. 
histolytica does not contain mitochondria, which is why it obtains its source of 
energy via anaerobic process by releasing glucose from the stored glycogen mass. 
Trophozoite of E. histolytica contains one round nucleus, in which the genetic 
material (DNA) is concentrated in the form of a small, dense, centrally located 
karyosome and peripherally, evenly deployed chromatin. The shape and position of 
the karyosome and the placement of chromatin in the cell nucleus is the characteristic 
of E. histolytica, which is used in their differential diagnosis. E. histolytica 
trophozoite secretes specific proteolytic enzymes such as hyaluronidase, cysteine 
proteinase that can degrade and lyse human cells and tissues. The image of E. 
histolytica trophozoite is shown in Figure 1.2. 
 
 
               Figure 1.2: Trophozoite stage of E. histolytica (Technology, 2015) 
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The cyst of E. histolytica is the infective stage. It can survive in adverse conditions in 
the external environment for many days. The cyst has a diameter of 10-20 μm. It is 
usually round and contains 1, 2, 3 or 4 nuclei with karyosome peripherally placed 
chromatins. A mature cyst of E. histolytica usually contains irregular shaped 
glycogen in its cytoplasm which is stained dark or orange-brown with Lugol’s iodine. 
In addition, the cyst also contains blunt finished chromatoidal bars. These structures 
are clearly visible in preparations stained with iodine or Trichrome (Gömöri-
Wheatley technique). Figure 1.3 shows the cyst E. histolytica  (Technology, 2015). 
 
          Figure 1.3: Cyst stage of E. histolytica (Technology, 2015) 
 
1.2  Epidemiology of Amoebiasis 
1.2.1 Geographical Distribution of Amoebiasis 
Amoebiasis, an infection by protozoa E. histolytica is appraised as the third leading 
parasitic cause of human mortality after malaria and schistosomiasis (Nath et al., 
2015). Amoebiasis accounted for 40,000 to 100,000 cases of death each year. Only 
10 to 20% of the persons infected by E. histolytica developed the symptoms and 
manifested as amoebiasis. Significant progress has been made on the classification of 
Entamoeba in which the existent of two identical species were confirmed, namely the 
pathogenic E. histolytica and non-pathogenic E. dispar. According to the report 
released by The Pasteur Institute in 2012, in some tropical regions, the prevalence in 
E. histolytica may even reach 20% of the population. One percent of world 
 5 
 
population is infected by E. histolytica; this is why E. histolytica is the second 
leading cause of mortality among the human parasites. Amoebiasis is genuinely a 
major handicap to the health of the people under fairly poor hygienic conditions and 
primarily living under the poverty line, mostly in the developing countries like India, 
Bangladesh and Mexico. In Africa surveys and researches conducted in Sudan, Ivory 
Coast, Ethiopia, Nigeria, Egypt and South Africa revealed the fact that in some local 
regions the prevalences of amoebiasis were high. On the contrary, rare cases were 
reported in developed countries like United States of America (USA) and Western 
European countries (Hategekimana, Saha & Chaturvedi, 2016). 
 
1.2.2 Distribution of Amoebiasis in Malaysia 
The prevalences of E. histolytica, E. histolytica/E. dispar/E. moshkovskii among the 
Orang Asli communities in Malaysia have been reported to range from 1% to 83% 
by many researchers since the 1960s. Most of the reports did not take into 
considerations that the three amoeba species were morphologically identical and 
cannot be distinguished by microscopy. Recently the separate prevalences of E. 
histolytica and E. dispar among the Orang Asli communities were estimated at 
13.2% and 5.6%, respectively. These were determined based on the re-description of 
pathogenic E. histolytica and non-pathogenic E. dispar and E. moshkovskii (Anuar et 
al., 2012). 
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1.2.3 Reservoir, Source and Transmission of Amoebiasis 
Amoebiasis caused by the protozoan parasite E. histolytica. According to WHO, 
transmission of amoebiasis occurs via the faecal–oral route, either directly by person-
to-person contact or indirectly by eating or drinking faecally contaminated food  or 
water with cyst of E. histolytica (World Health Organization, 2016). 
 
1.3  Pathogenesis of Amoebiasis 
E. histolytica can be found mainly in countries, areas, and institutions with poor 
sanitation and water systems contaminated with cysts of E. histolytica (World Health 
Organization 2016). Acid in human stomach kills E. histolytica trophozoites but not 
the cysts. In fact the cysts can resist the strong stomach acid and excyst into 
trophozoites in the lumen of the small intestine.  
 
Successful invasion of E. histolytica on host depends on the parasite abilities to cross 
the intestinal or hepatic barrier, resist and escape the host responses, destroy the 
tissue and migrate to the host microenvironment. Hence various diverse factors have 
to be coordinated for a successful invasion of its host. Some important molecules 
have been studied for their roles in tissue invasion: adherence, cytotoxicity, cell 
killing and phagocytosis as well as the onset of host immune responses (Faust 
&Guillen, 2012). The invading trophozoites may cause asymptomatic luminal 
colonization, amebic colitis and amebic liver abscess is E. histolytica (Petri Jr & 
Haque 2015).  
 
The initial contact of the trophozoite to host luminal wall is mediated by E. 
histolytica Gal/GalNAc lectin, which binds to carbohydrate determinants on the wall. 
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With the aid of amebic lectin, cytolysis occurs after adherence in the process that 
involves phagocytic ingestion of the host cells in bites, called “trogocytosis-like”. 
Figure 1.4 shows the process of cytolysis. However, killing of host cells is not caused 
by an isolated toxin, inasmuch as parasite extracts have no cytotoxic activity. Lastly, 
in multicellular organisms, phagocytosis is the final step in the apoptotic pathway 
and serves to limit inflammation by preventing spillage of toxic intracellular contents 
of dead cells. Although amoebic killing of cells by contrast involves phagocytosis 
followed by death, phagocytosis could similarly limit the host inflammatory response 
and enable E. histolytica to establish a persistent infection. 
 
Figure 1.4: Trogocytosis-like killing of host cells by E. histolytica [Scientific 
American (2014). Obtained on 18 August 2017 at 
https://www.scientificamerican.com/article/amoeba-takes-bites-of-human-cells-to-
kill-them/]. 
 
Human colon produces mucin which binds to and inhibits E. histolytica Gal/GAlNAc 
adherence lectin. However, E. histolytica encodes for at least 44 cysteine proteinases 
genes, in which some of the cysteine proteases are reported to be potentially 
important for the degradation of colonic mucin glycoproteins and digestion of 
hemoglobin and villin of intestinal epithelial cells (Mandell, Douglas & Bennett 
2015). 
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1.4  Host Immunity    
1.4.1 Innate immunity: 
E. histoytica trophozoite is a microaerophilic protozoan which is killed in host 
environment with high oxygen content such as in the presence of reactive oxygen 
species (ROS) and nitirc oxide (NO). 
 
Neutrophils are the earliest innate cellular immune response for both intestinal and 
hepatic amebiasis. It is one of the first immune cells to respond to amoebic invasion. 
As a consequence of interaction with E. histoytica trophozoites, neutrophils become 
activated and release reactive oxygen species (ROS) which are toxic to the 
trophozoites. Besides neutrophils, macrophages produce NO to kill the trophozoites 
when they are stimulated with INF-gamma or TNF-alpha.   
 
 
In adaptive immunity, mucosal immunoglobulin A response directed at the 
carbohydrate recognition domain (CRD) of the parasite Gal/GalNAc lectin was 
reported to be potentially important as it was associated with protection of preschool 
children against amoebiasis in Bangladesh (Haque et al., 2001). Further researches 
on the dynamics of the interaction of E. histolytica trophozoite with its host are 
ongoing in trying to better understand the pathogenesis of amebiasis (Moonah et al., 
2013).  
 
 
1.5 Treatment of Amoebisis 
There are four antiparasitic drugs commonly used to combat E. histolytica infection 
which is metronidazol, Tinidazole, Paromomycin, and Diloxanide furoate. Among 
these, Metronidazol is commonly used to kill E. histolytica infection. Metronidazol is 
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belong to nitroimidazole group. It takes advantage of the bacteria-like enzyme 
known as nitroreductase in microaerophilic E. histolytica. The activation step of 
metronidazole begins through enter the cell as a prodrug by passive diffusion and 
electron transfer to the nitro, resulting in formation of short-lived cytotoxic nitroso 
free radical which includes the transfer of an electron to the nitro group of the drug 
that can interact with the DNA molecule. Then, activated metronidazole compound 
can inhibit DNA synthesis and induce DNA damage through oxidation, resulting in 
single- and double-strand breaks that lead to DNA degradation and cell death. 
Another drug that can be used to combat E. histolytica, known as tinidazole, also has 
the same mechanism of action as metronidazol (Lofmark, Edlund & Nord 2010). 
 
Moving on, the third antiparasitic drug used to treat E. histolytica infection is known 
as paramomycin. Its mechanism of action is mainly to block the peptide synthesis at 
the level of ribsosome (Murray, Rosenthal & Pfaller 2013). The last drug used as part 
of antiparasitic therapy is diloxanide furoate, which has unknown mechanism of 
action against E. histolytica. Table 1.1 shows drug therapy for treatment of 
amoebiasis with their respective dosage and duration (Mandell, Douglas & Bennett 
2015). 
 
 
 
 
 
 
 
 10 
 
                    Table 1.1: Drug therapy for treatment of amoebiasis (Mandell,  
                    Douglas & Bennett 2015). 
 
 
 
1.6 Prevention and Control of Amoebiasis 
Methods of prevention and control are much better than drugs. Elimination of the 
cycle of infection requires education about the routes of transmission and adequate 
sanitation measures, especially through chlorination and filtration. Water should be 
boiled and fruits and vegetables should be thoroughly cleaned before consumption 
(Mandell, Douglas & Bennett 2015). Unfortunately, there are no known drugs for 
chemoprophylaxis usage exists, but steps for prevention and control of amoebic 
infection are available as of yet. 
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1.7 Diagnosis of Amoebiasis 
1.7.1 Laboratory Diagnosis 
The laboratory tests used at present to diagnose amoebiasis are microscopys, antigen 
detection, Culture, ultrasound, biopsy serology tests and polymerase chain reaction. 
Intestinal amoebiasis may present as amoebic colitis or amoebic dysentery. Stool 
samples for three consecutive days are collected and sent for microscopy 
examination. Generally, stool examinations of patients suffering from amoebic liver 
abscess are negative. Polyvinyl alcohol (PVA) fixative or Schaudinn’s fixative 
should be used during the stool specimen collection to preserve the fragile and rapid 
deteriorating trophozoites. However, direct wet mount on fresh stool samples are 
commonly performed in many laboratories to save cost and time, but the sensitivity 
is low. Therefore concentration techniques such as zinc sulphate flotation technique 
and formalin ether sedimentation technique should be performed on ‘negative’ 
samples to decrease the possibility of false negative result. In many cases, live 
trophozoites could not be detected via concentration technique, as many will 
deteriorate during the process (Parija et al., 2014). 
 
1.7.1.1  Stool Microscopy 
The diagnosis of amoebiasis is mainly based on clinical syndrome and microscopic 
examination of stool samples, which posed many problems. The first problem is poor 
correlation between patients infected with amoeba and the development of 
symptomatic amoebiasis, as 90% of infected individuals present as asymptomatic 
carriers and amoebiasis is often clinically under-diagnosed in developing areas, 
unless there is history of the patients returning from tropical area (Barrett-Connor, 
1971; Parija et al., 2014). On the other hand, because of the morphological similarity 
 12 
 
with the non-pathogenic strains, such as E. dispar, over-diagnosis and treatment were 
common. The second problem is the poor sensitivity of laboratory methods and low 
laboratory proficiency (Mukhopadhyay et al., 2000; Fotedar et al., 2007a). However, 
microscopic examination of stool samples for the protozoan morphology is still 
commonly practiced in many parasitology laboratories, especially in underdeveloped 
countries. It is difficult or even impossible to microscopically differentiate among all 
the human intestinal protozoa with similar morphological features, as shown in 
Figure 1.5 and Table 1.2 (Haque et al., 1995; WHO, 1997; Tanyuksel and Petri, 2003; 
Haque and Petri, 2006; Fotedar et al., 2007b; Liang et al., 2009a). 
 
 
 
 
 
 
 
Table 1.2 Morphologic features and pathogenicity of intestinal amoeba 
(Tanyuksel and Petri, 2003) 
 
Characteristics E. histolytica, 
E. dispar and 
E. 
moshkovskiia 
E. 
hartmanni 
E. coli E. polecki E. nana 
Trophozoites 
(size, nucleus, 
and movement) 
15-20 μm; 1 
nucleus; 
actively motile 
cytoplasmic 
protrusions, 
quickly finger 
shaped 
pseudopodium 
8-10 μm; 1 
nucleus; 
nonsuccess
ive 
20-25 μm; 1 
nucleus; slow 
movement, 
short and 
blunt 
pseudopodiu
m 
15-20 μm; 1 
nucleus; 
motility 
resembles E. 
coli 
7-9 μm; 1 
nucleus, blunt 
and hyaline 
pseudopodiu
m, slow 
movements 
Cysts (size, 
nucleus) 
12-15 μm; 
mature cyst 
has 4 nuclei, 
immature cyst 
has 1 or 2 
nuclei 
6-8 μm; 
mature cyst 
has 4 
nuclei; 
immature 
cyst has 1 
or 2 nuclei; 
2 nucleated 
cysts very 
common 
15-25 μm; 
mature cyst 
has 8 nuclei, 
rarely 16 or 
more nuclei 
10-15 μm; 1 
nucleus, very 
rarely 
binucleated or 
quadrinucleate
d 
6-8 μm; 4 
nuclei 
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Characteristics E. histolytica, 
E. dispar and 
E. 
moshkovskiia 
E. 
hartmanni 
E. coli E. polecki E. nana 
Appearance of 
trophozoites 
Stained 
trophozoites 
with fine, 
uniform 
granules of 
peripheral 
chromatin, and 
small central 
karyosome in 
nucleus; 
ingested RBC 
(E. dispar and 
E. moshkovskii 
are similar to 
E. histolytica 
trophozoites, 
sometimes 
ingested 
RBCs) 
Nuclear 
structure 
similar to 
E. 
histolytica; 
cytoplasm 
finely 
granular; 
ingested 
bacteria 
Nuclear with 
irregular 
cluster of 
peripheral 
chromatin; 
large, 
irregular, 
eccentric 
karyosome 
Nucleus with 
minute central 
karyosome, 
with fine 
granules of 
peripheral 
chromatin, 
finely granular 
cytoplasm; 
ingested 
bacteria 
Nucleus with 
large 
karyosome; 
no peripheral 
chromatin 
Appearance of 
cysts 
Typical 
nuclear 
structure is 
uniform size in 
having both 
karyosome 
and peripheral 
chromatin, 
chromatoidal 
bars with 
squared or 
rounded ends 
Typical 
nuclear 
structure, 
chromatoid
al bars with 
rounded or 
squared 
ends 
Typical 
nuclear 
structure, 
sliver-shaped 
or irregular 
chromatoidals 
Mononucleate
d; large central 
karyosome; 
chromatoid 
bars with 
pointed or 
angular ends, 
inclusion 
masses 
Chromatin, 4 
nuclei with 
large 
karyosomes 
and no 
peripheral 
chromatin 
Pathogenicity Only E. 
histolytica is 
pathogenic (E. 
dispar and E. 
moshkovskii 
are 
nonpathogenic
) 
Nonpathog
enic 
Nonpathogeni
c 
Nonpathogeni
c 
Nonpathogeni
c 
aE. moshkovskii is present in free-living protozoa. 
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Figure 1.5 Amoebas found in stool specimens of humans (Baron, 1996) 
  
The microscopy examination of stool samples can be performed directly or after 
staining. For direct stool examination, which primarily looks for stool consistency 
(liquid, soft or formed), blood and mucus. Liquid specimens should be examined 
within 30 minutes of passage; semiformed, within 1 hour of passage; and formed, 
within 24 hours of passage. Trophozoite and cyst can be easily identified, but the 
nucleus or central karyosome is difficult to see (Garcia &Shimizu, 1998, Engelkirk, 
& Duben-Engelkirk, 2008,). There are many stains that can be used for staining and 
can the internal features of trophozoite and cyst are easily visible e.g. (Lugol’s iodine 
stain, methylene blue, Giemsa, Wright’s and iodine-trichrome). However, 
Wheatley’s trichrome staining and modified iron haematoxylin permanent stain have 
been suggested for routine used (Fotedar et al., 2007a).Wheatley’s trichrome 
staining, trophozoites in stool samples are stained blue purple, while the background 
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is stained light green. In addition, this stain also displays good chromatin lining and 
central karyosome of the nucleus. 
 
1.7.1.2  Stool Antigen Detection 
Antigen detection test for diagnosis of intestinal amoebiasis offers several 
advantages. This test is able to differentiate between E. histolytica and E. dispar. The 
most commonly used antigen detection test is the TechLab E. histolytica II (TechLab, 
Blacksburg, VA), which is based on detection of E. histolytica lectin. This kit 
showed high sensitivity and specificity for detection of E. histolytica in stools 
samples; hence it is very useful for the diagnosis of intestinal amoebiasis. Previous 
studies had shown it has sensitivities of 96%, 41%-74%, and 43% when it was used 
to test for the presence of Gal/GalNAc lectin in the serum, liver abscess pus, and 
stool specimens collected at the time of diagnosis of amebic liver abscess. However, 
the commercially available tests are too costly for most developing countries, as 
compared to conventional microscopic methods (Roy et al., 2005; Haque et al., 
2000). 
  
1.7.1.3  Stool Culture 
There are three types of culture techniques for cultivation of E. histolytica namely 
xenic, monoxenic and axenic culture methods. In xenic cultivation, E. histolytica can 
be detected by using media such as Locke-egg medium, Robinson’s medium or 
TYSGM-9 medium. In either monoxenic or axenic method, the media that can be 
used are TYI-S-33, YI-S and LYI-S-2 media. Culture and isolation of E. histolytica 
can be done using stool specimens, rectal biopsy specimens and liver abscess 
aspirates. However, the success rate is only between 50% and 70% with a significant 
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false-negative rate. Besides, such culture technique for E. histolytica from stool is 
only available in few research laboratories worldwide. Furthermore, culturing of the 
parasite is a difficult, expensive and labour-intensive technique, so nowadays this 
method is no longer a routine practice in diagnostic laboratories (Clark & Diamond, 
2002). 
 
1.7.1.4  Molecular Diagnosis  
PCR assay can differentially detect specific genes of Entamoeba species in stool 
specimens and liver pus aspirates. This method is very sensitive as it is reported to 
detect as little as 10 pg of E. histolytica and E. moshkovskii DNA, and 20 pg of E. 
dispar DNA using conventional PCR test (Hamzah et al., 2006). DNA extraction 
step is crucial prior to PCR test because the presence of PCR inhibitors in faeces (e.g. 
heme, bilirubins, and bile salts) causes false-negative results. Thus, optimisation of 
faecal DNA extraction step is required in order to remove the unwanted inhibitors 
results (Holland et al., 2000). 
 
On the other hand, PCR assay is able to detect amoebic DNA in liver pus aspirates 
with overall sensitivity rate of ~80%. Besides, detection of amoebic DNA via PCR 
test can be adopted on other clinical samples such as blood, urine and serum, too. 
(Ahmad et al., 2007; Parija and Khairnar, 2007; Othman et al., 2010). The study 
showed that saliva and urine were the diagnostic tools for ALA, with the sensitivity 
of 97% (Haque et al., 2010).  
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In summary, PCR best tests and assays for the diagnosis of E. histolytica Abscess are 
as follow:   
 PCR is known with as highly sensitive and specific in detection and 
differentiating E. histolytica and E. dispar, as compared to ELISA (Mirelman 
et al., 1997). 
 Various PCR primer pairs have been developed to effectively distinguish 
pathogenic E. histolytica from non-pathogenic E. dispar and E. moshkovskii, 
which include small-subunit RNA nucleotide sequence, tDNA associated 
short tandem repeats (STRs), DNA highly repetitive sequences, extra-
chromosomal circular DNA, hemolysin gene (HLY6) LSU rRNA, cysteine 
proteases and lectin gene (Zindrou et al., 2001; Fotedar et al., 2007b; Fotedar 
et al., 2007c; Paul et al., 2007).  
 One of the disadvantages of using antibody assay is that it cannot 
differentiate current from past infections; PCR diagnostic method has the 
potential to overcome this limitation by detecting the presence of parasites in 
the clinical samples  (Rochelle et al., 1997). 
 It has greater sensitivity, rapid analysis, simultaneous detection of multiple 
pathogens and the ability to differentiate between species by using species-
specific primer pairs. 
 
1.7.1.5  Serology 
1.7.1.5.1 CSA Antigen 
The axenic culture of E. histolytica trophozoites using TYI-S-33 medium, 
established in 1961 by Louis Diamond and his team members has led to the rapid 
pace of scientific discovery on this parasite, as many in vivo and in vitro studies can 
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be conducted by means of pure culture. Besides, pure antigen can be produced 
directly from the culture for diagnosis use, as well as the study of sero prevalence 
(Wong et al., 2017). 
 
 
1.7.1.5.2 ESA Antigen  
Excretory and secretory (ES) products contain virulence factors like amoebapores, 
cysteine proteases, collagenases, glycosidases and other proteases that has been 
hypothesized to contribute to the pathogenesis of E. histolytica. During active 
infection, E. histolytica trophozoites secrete and/or excrete products into the host 
environment (Bhattacharya et al., 1998). These secreted products were suggested to 
be important for the establishment and maintenance of the parasite in its host (Munoz 
et al., 1982; Gitler et al., 1984; Guerrero-Manriquez et al., 1998; Debnath et al., 
2005; Moncada et al., 2005). As compared to conventionally used crude soluble 
antigen in an ELISA format, ESA was shown to increase the detection rate in patient 
suffering from acute amoebic dysentery and asymptomatic cyst passers groups, as 
well as be equally sensitive for detection of ALA (Pal et al., 1996). 
 
1.7.1.5.3 Amoebic Lectin Antigen  
TechLab E. histolytica II (TechLab, Blacksburg, VA) has also been investigated for 
use in detection of E. histolytica circulatory lectin antigen in stool, saliva, serum and 
aspirated liver pus from patients (Haque &Petri, 2006). The detection of lectin 
antigen in the aspirated liver pus samples was shown to be 100%, provided the 
specimen was taken prior to any treatment. Detection of lectin antigen in the saliva 
was shown to be 70% in sensitivity; while, the sensitivity for detection of lectin 
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antigen in the human serum samples with ALA was reported to be 75% for the late 
stage of infection and 100% for the first three days after onset of the symptoms 
patients. There is study  showing sensitivity for detection of lectin antigen in saliva 
samples of ALA patients was only 22%, while higher (66%) in cases of amoebic 
colitis (Abd-Alla et al., 2000). A summary of the sensitivities and specificities of 
antigen detection tests for diagnosis of amoebiasis is shown in Table 1.3 (Tanyuksel 
& Petri, 2003; Fotedar et al., 2007a).    
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Table 1.3 Commercial assays used to identify E. histolytica 
 
aCompared to culture and isoenzyme analysis ,bCompared to culture,cCompared to zymodeme analysis  
dCompared to microscopy ,eCorrelation to zymodeme analysis. 
fCorrelation of TechLab E. histolytica for detection of E. histolytica, but not E. dispar  
gCompared to ProSpecT ELISA ,hCompared to microscopy ,iCompared to O&P and permanent stains  
jReference 91,kReference 161 (with use of E. histolytica antigen detection as the reference standard). 
lReference 204,mReference 180,nReference 182. NA, not available,oKP, kit prospectus 
pNP, not published data. 
 
 
1.7.1.6  Diagnosis of Extraintestinal Amoebiasis 
The examination for extraintestinal amoebiasis is often started when patient 
experiences the symptoms of fever, nausea, hepatomegaly and tenderness in the right 
upper quadrant. Radiological imaging is performed to investigate the presence and 
size of the abscess. Depending on the physical condition of the patient and size of the 
abscess; The physician may aspirate the abscess for microscopy examination to 
check for the presence of live trophozoites, and also to rule out the possibility of liver 
necrosis (Salles et al., 2003). For extraintestinal amoebiasis cases, the symptoms of 
intestinal amoebiasis may not be present, and trophozoites and cysts are rarely found 
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in the stool samples. Therefore, many physicians often treat the patient based on the 
combination of clinical manifestations, serological test and radiological imaging 
(Baron, 1996). In addition to that, abdominal imaging techniques such as ultrasound, 
computer tomography, and magnetic resonance are useful adjuncts for diagnosis of 
intestinal and extraintestinal disease. 
 
1.8 Rationale of the Study 
Orang Asli who dwelled in remote settlements with substandard sanitation and poor 
supply of safe water are high risk group for amoebiasis (Ngui et al., 2012). For 
control and prevention measures, continuous surveillance of the prevalence and 
distribution of anti-amoebic antibody in Orang Asli settlements are important (Alum 
et al., 2010). However, mass screening by commercial kits is impractical due to the 
high cost. Cheaper but valid in-house assay should be used instead to attain cost-
effective and sustainable outcome (Tan et al., 2013). Customized CSA-ELISA is 
widely used for detection of anti-amoebic antibody, but the undefined antigenic 
properties and high proteases content have reduced assay reproducibility (Flores et 
al., 2016). Otherwise, customized ELISA using rLectin protein with defined 
antigenic properties and relatively ease to produce might be more suitable for mass 
screening purpose (Stanley et al., 1998). 
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1.9 Objective of the study 
The general objective of the study is to compare the efficiencies customized CSA- 
and rLectin-ELISAs for detection of anti-amoebic antibody in selected Orang Asli 
serum samples defined by commercial IHA. 
 
The specific objectives include:  
1. To produce E. histolytica CSA and rLectin protein for detection 
2. To develop and optimize the customized CSA- and rLectin-ELISAs 
3. To compare the efficiencies of both customized ELISAs   
 
 
 
1.10 Overview of the Study 
The methodology of the study is as shown below. 
 
Axenic Culture of E. histolytica 
Preparation of Crude Soluble 
Antigen 
Revived of E. coli BL21AI-
pET14b-EhCL 
Expression and Purification of 
Recombinant CL Protein 
Preparation of Antigen 
Development of Indirect ELISA 
Screening of Selected Orang Asli Serum Samples 
Data Analysis 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 Materials 
2.1.1 Entamoeba histolytica culture 
E. histolytica HM-1:IMSS was first isolated in 1967 from an adult male in Mexico 
City who was suffering from rectal ulcer. It was then gradually adapted to axenic 
culture in Hospital de Especialidades, Instituto Mexicano del Seguro Social, Mexico 
City. In this study, this axenic strain was a kind contribution from Dr. Alfonso 
Olivos-Garcia from Departamento de Medicina Experimental, Facultad de Medicina, 
Universidad Nacional Autónoma de México.  
 
2.1.2 Escherichia coli Strain 
E. coli BL21AI (Invitrogen, USA) carrying pET14b-rLectin was used for production 
of recombinant lectin protein. 
 
2.1.3 Serum Samples 
Archived Orang Asli serum samples used in the present study were previously 
analysed by indirect haemagglutination assay (Dade Behring Marburg GmbH, 
Marburg, Germany). The use of these serum samples was previously approved by 
Malaysian Ministry of Aborigine Affairs (Appendix 1). Serum samples used for 
evaluation of CSA- and rLectine-ELISAs were as follow: 
Group I: IHA seropositive serum samples: Anti-amoebic antibody titer >128 (N=33) 
Group II: IHA seronegative serum samples: Negative by IHA screening (N=30) 
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2.1.4 List of Chemicals 
Chemicals used in this study are listed in Table 2.1. 
 
2.1.5 List of Kits and Consumables 
Kits and consumables used in this study are listed in Table 2.2. 
 
2.1.6 List of Equipment 
Equipment used in this study is listed in Table 2.3. 
 
2.1.7 List of Buffers and Reagents 
Buffers and reagents used in the present study are listed in Appendix 2. 
  
